Promotion and Mitigation Factors Leading to Illegal Tobacco Purchases
1 other identifier
interventional
65
1 country
1
Brief Summary
This study will investigate the effects of promotion factors and mitigation strategies on legal and illegal tobacco purchases for different tobacco-user types.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedStudy Start
First participant enrolled
January 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedResults Posted
Study results publicly available
February 10, 2026
CompletedFebruary 10, 2026
January 1, 2026
1.2 years
August 14, 2023
September 10, 2025
January 21, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Percent Budget Spent on Illegal Cigarettes Across Policy Conditions
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on illegal cigarettes across all trials was calculated for each policy scenario.
1 day
Percent Budget Spent on Legal Cigarettes Across Policy Conditions
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on legal cigarettes across all trials was calculated for each policy scenario.
1 day
Percent Budget Spent on E-cigarettes Across Policy Conditions
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on e-cigarettes across all trials was calculated for each policy scenario.
1 day
Percent Budget Spent on Nicotine Replacement Therapy Across Policy Conditions
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on nicotine replacement theray across all trials was calculated for each policy scenario.
1 day
Percent Budget Spent on Oral Nicotine/Tobacco Across Policy Conditions
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on oral nicotine/tobacco across all trials was calculated for each policy scenario.
1 day
Study Arms (2)
Experimental: Exclusive cigarette smokers
EXPERIMENTALExclusive cigarette smokers will be recruited and will be exposed to all of the conditions described in the intervention section.
Experimental: Dual cigarette/ nicotine vaping product users
EXPERIMENTALDual cigarette and nicotine vaping product users will be recruited and will be exposed to all of the conditions described in the intervention section
Interventions
In the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM. In the low nicotine conditions, a ban will permit only VLNCs in the LETM and preferred cigarettes will be available in the iETM.
Penalties: Penalties will be presented as a 60% chance of getting caught making illegal purchases. The consequences of illegal purchases include not receiving any study products from the ETM if they were caught and randomly drew that trial.
Eligibility Criteria
You may qualify if:
- Provide informed consent
- Be at least 21 years of age or older
- Provide a breath sample for measuring carbon monoxide (CO ≥ 8 ppm)
- Stable tobacco use patterns for at least two months
- For exclusive cigarette smokers:
- Smoke at least 10 cigarettes daily and do not use NVPs regularly (no more than 9 times in the last month).
- For dual cigarette/NVP users:
- Smoke at least 10 cigarettes daily and use NVPs at least 3 times in a week (report use of closed nicotine salt system)
You may not qualify if:
- Have plans to move out of the area
- Have a serious or unstable physical or mental health condition
- Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement
- Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study
- Being pregnant or lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, 24016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Roberta Freitas-Lemos
- Organization
- Fralin Biomedical Research Institute at VTC
Study Officials
- PRINCIPAL INVESTIGATOR
Roberta Freitas-Lemos, Ph.D.
Fralin Biomedical Research Institute at Virginia Tech Carilion
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 14, 2023
First Posted
August 21, 2023
Study Start
January 4, 2024
Primary Completion
February 28, 2025
Study Completion
March 31, 2025
Last Updated
February 10, 2026
Results First Posted
February 10, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The study team will share de-identified data upon request.